// App-Quantinova.ai

e20093 : Evaluation of anti-cancer stem cell activity of the anti-DLL4 antibody MEDI0639 in a phase I clinical trial of SCLC.

Researchers

Presenter

  • Haifeng Bao

Principal Investigators

  • Xiaoru Chen

  • Suneetha Thomas

  • Xiaoqing Shi

  • Patrick Strout

  • Elaine Hurt

  • Song Cho

  • Patricia A Burke

  • Mohammed M. Dar

Medical Centers

  • MedImmune, Gaithersburg, MD

  • MedImmune, Gaithersburg, MD

  • MedImmune, Gaithersburg, MD

  • MedImmune, Clarksburg, MD

Locations

  • United States

Companies

  • MedImmune Inc. (Astr

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

  • Small cell lung cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • MEDI 0639

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • NCT01577745

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved